• "People are more afraid of a dementia diagnosis than of death": The challenges of supporting advance care planning for persons with dementia in community settings
• "What choice do we have?" Reactive and proactive decision-making for aging in place with dementia
• 15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN
• A golden age of muscarinic acetylcholine receptor modulation in neurological diseases
• A multi-scale feature selection module based architecture for the diagnosis of Alzheimer's disease on [(18)F]FDG PET
• A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce
• A Reliable and Accessible Caregiving Language Model (CaLM) to Support Tools for Caregivers: Development and Evaluation Study
• A survey study of Alzheimer's stigma among Black adults: intersectionality of Black identity and biomarker diagnosis
• Amyloid beta, gamma-secretase, and familial Alzheimer's disease
• APOE epsilon4-associated downregulation of the IL-7/IL-7R pathway in effector memory T cells: Implications for Alzheimer's disease
• Assessing and recovering Alzheimer's disease: a comparative analysis of standard neuropsychological approaches and virtual reality interventions with the use of digital storytelling
• Assessing the clinical meaningfulness of slowing CDR-SB progression with disease-modifying therapies for Alzheimer disease
• Association between glycemic status and all-cause mortality among individuals with dementia: a nationwide cohort study
• Astrocyte tau deposition in progressive supranuclear palsy is associated with dysregulation of MAPT transcription
• BPSD reconsidered: diagnostic considerations to preserve personhood in persons with dementia
• Broadening Horizons: Exploring the Cathepsin Family as Therapeutic Targets for Alzheimer's Disease
• Care partner evaluation of the behaviors in the Cohen-Mansfield Agitation Inventory
• Characterization of Ptau181 Among a Diverse Community-Based Cohort: A HABS-HD Study
• Clinical application of whole genome sequencing in young onset dementia: challenges and opportunities
• Clinical Manifestations
• Cognitive aging in rural communities: preliminary memory characterization of a community cohort from Southern Nevada
• Comparing research attitudes in Down syndrome and non-Down syndrome research decision-makers
• Correction: The Role of Gut Microbiota in the Neuroprotective Effects of Selenium in Alzheimer's Disease
• Cortical neurodegeneration caused by <em>Psen1</em> mutations is independent of Aβ
• COVID-19 outcomes among patients with dementia and age-matched controls who were hospitalized in 21 US health-care systems
• Cultural adaptation of the brain health assessment for early detection of cognitive impairment in Southeast Nigeria
• Dementia with Lewy bodies and gait neural basis: a cross-sectional study
• Design and validation of the ADNI MR protocol
• Determinants of quality of life in French nursing home residents across cognitive levels: a comparative study using convergent mixed-methods
• Developing Topics
• Disrupted mitochondrial response to nutrients is a presymptomatic event in the cortex of the APP(SAA) knock-in mouse model of Alzheimer's disease
• Dyadic Ambivalence in Couples Managing Early-Stage Alzheimer's Disease: Linking Behavioral and Psychological Symptoms of Dementia to Life Satisfaction
• E22G Abeta40 fibril structure and kinetics illuminate how Abeta40 rather than Abeta42 triggers familial Alzheimer's
• Enhancing Outcomes in Alzheimer's Disease: Exploring the Effects of a Diversified Rehabilitation Program Combined with Donepezil on Apathy, Cognitive Function, and Family Caregiver Burden
• Experiences of African American caregivers providing care for family living with Alzheimer's disease: A descriptive phenomenological study
• Exploring Causal Relationships Between Gut Microbiota and Alzheimer's Disease: A Bidirectional Mendelian Randomization Study
• Exploring Intrinsic Disorder in Human Synucleins and Associated Proteins
• External Validation of the Charlson Comorbidity Index-based Model for Survival Prediction in Thai Patients Diagnosed with Dementia
• Factors affecting support: experiences of Iranian older spousal caregivers of people with Alzheimer's disease and their support resources
• Feasibility and Determinants of Performance for a Tablet-Based Cognitive Assessment Tool in Rural and Urban Southeast Nigeria
• Fluvoxamine maleate alleviates amyloid-beta load and neuroinflammation in 5XFAD mice to ameliorate Alzheimer disease pathology
• Germacrone: A Multi-targeting Sesquiterpene with Promising Anti-cancer and Chronic Disease Applications
• Human Leukocyte Antigen and microRNAs as Key Orchestrators of Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review
• Identification of Meibomian gland stem cell populations and mechanisms of aging
• Identification of older adults with Alzheimer's and related dementias among patients newly diagnosed with cancer: A comparison of methodological approaches
• Impact of an improved outdoor space on people with dementia in a hospital unit
• Increased SNAI2 expression and defective collagen adhesion in cells with pediatric dementia, juvenile ceroid lipofuscinosis
• Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders
• Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer's disease
• Influence of Different Diagnostic Criteria on Alzheimer Disease Clinical Research
• Inhibitor of bromodomain and extraterminal domain proteins decreases transcription of Cd33 in the brain of mice subjected to systemic inflammation; a promising strategy for neuroprotection
• Innovative drug discovery strategies in epilepsy: integrating next-generation syndrome-specific mouse models to address pharmacoresistance and epileptogenesis
• Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes
• Knowledge and attitudes about dementia among nursing students in Vietnam: a cross sectional study
• Knowledge, Awareness, and Perceived Threat Toward Alzheimer's Disease Among the Family Caregivers of Individuals with Chronic Physical Conditions in Bangladesh
• Long noncoding RNA GAS5 acts as a competitive endogenous RNA to regulate GSK-3beta and PTEN expression by sponging miR-23b-3p in Alzheimer's disease
• Long-Term Dementia Risk in Parkinson Disease
• Loss of DNA glycosylases improves health and cognitive function in a C. elegans model of human tauopathy
• MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy
• Meaningful benefit of disease-modifying treatment: Evaluating changes in health-related resource use
• Methods for joint modelling of longitudinal omics data and time-to-event outcomes: Applications to lysophosphatidylcholines in connection to aging and mortality in the Long Life Family Study
• Mice lacking <em>Astn2</em> have ASD-like behaviors and altered cerebellar circuit properties
• Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming
• Multi-peptide characterization of plasma neurofilament light chain in preclinical and mild Alzheimer's disease
• Neurofibrillary tangle-bearing neurons have reduced risk of cell death in mice with Alzheimer's pathology
• Nomination of a novel plasma protein biomarker panel capable of classifying Alzheimer's disease dementia with high accuracy in an African American cohort
• North Macedonia interprofessional dementia care (NOMAD) - personalized care plans for people with dementia and caregiver psychoeducation delivered at home by interprofessional teams
• Osteopontin: A novel marker of pre-symptomatic sporadic Alzheimer's disease
• Palmitoylation of synaptic proteins: roles in functional regulation and pathogenesis of neurodegenerative diseases
• Parkinson's disease variant detection and disclosure: PD GENEration, a North American study
• Patient and public involvement in international research: Perspectives of a team of researchers from six countries on collaborating with people with lived experiences of dementia and end-of-life
• Performance Under Fire: Older Adult Cognitive Risks and Protections Under Heat Strain
• Photophysics of Molecular Probes for Amyloid-β Detection: Computational Insights into the Roles of Probe Linker and Functional Groups
• Plasma lipidomics in early APP/PS1 female mouse model and its relationship with brain: Is it affected by the estrous cycle?
• Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment
• Polyphenol-based polymer nanoparticles for inhibiting amyloid protein aggregation: recent advances and perspectives
• Primary lateral sclerosis associated with PSEN1 Pro284Leu variant in a Colombian family: Clinical and neuropathological features
• Pros and Cons of APOE4 Homozygosity and Effects on Neuroplasticity, Malnutrition, and Infections in Early Life Adversity, Alzheimer's Disease, and Alzheimer's Prevention
• Quantitative Analysis of Factors of Attrition in a Double-blind rTMS Study for Alzheimer Treatment
• Risk of Dementia in Different Types of Cancer Survivors: A Nationwide Cohort Study
• Role of 14-3-3 protein family in the pathobiology of EBV in immortalized B cells and Alzheimer's disease
• Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson's Disease
• Short- and long-term impact of aspirin cessation in older adults: a target trial emulation
• Single-Nucleus Landscape of Glial Cells and Neurons in Alzheimer's Disease
• Standard versus High Cardiopulmonary Bypass Flow Rate: A Randomized Controlled Subtrial Comparing Brain Injury Biomarker Release
• Stem cell therapeutics and gene therapy for neurologic disorders
• Subsyndromes and symptom clusters: Multilevel factor analysis of behavioral and psychological symptoms of dementia with intensive longitudinal data
• Suppression of the amyloidogenic metabolism of APP and the accumulation of Aβ by alcadein α in the brain during aging
• Telephone-based mindfulness intervention positively impacts family communication and stress within rural, African American dementia caregiving teams
• The global macroeconomic burden of Alzheimer's disease and other dementias: estimates and projections for 152 countries or territories
• The relationship between adult hippocampal neurogenesis and cognitive impairment in Alzheimer's disease
• The role of IL-1 family of cytokines in the pathogenesis and therapy of Alzheimer's disease
• The role of interferon beta in neurological diseases and its potential therapeutic relevance
• The role of MiRNA-34 family in different signaling pathways and its therapeutic options
• Therapeutic Effects of Arctiin on Alzheimer's Disease-like Model in Rats by Reducing Oxidative Stress, Inflammasomes and Fibrosis
• Transitional Care of People With Dementia and Caregivers in the ADRD-PC Trial: A Mixed Methods Study
• Transmembrane and coiled-coil 2 associates with Alzheimer's disease pathology in the human brain
• Ubiquitin-Proteasome System in the Different Stages of Dominantly Inherited Alzheimer's Disease
• VPS35 or retromer as a potential target for neurodegenerative disorders: barriers to progress
• Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy